Željko K.
- Country
- Croatia
- Department
- Gastroenterology and Hepatology
Research Overview
- Long-term Safety, Tolerability, and Efficacy of Balinatunfib in Adults with Crohn's Disease or Ulcerative Colitis: A Multicenter Extension Study
- A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tulisokibart in Participants with Moderately to Severely Active Ulcerative Colitis
- Long‑Term Safety and Efficacy of SPY001‑001 Monotherapy and Combination Therapy with Long‑Acting Antibodies in Adults with Ulcerative Colitis
Data & Insights
Has run more than one trial at 377 of 590 partner sites.
Specializations
Inflammatory Bowel Disease Research
This investigator specializes in treating inflammatory bowel diseases, with particular emphasis on novel therapeutic approaches for both Crohn's disease and ulcerative colitis. Their research encompasses innovative treatments including mirikizumab and etrasimod for managing moderate to severe cases.
- Crohn's Disease Management
- Ulcerative Colitis Treatment
- Novel Therapeutic Agents
Autoimmune Gastrointestinal Disorders
The investigator focuses on treating celiac disease and related autoimmune conditions affecting the digestive system. Their work includes evaluating new therapeutic options for patients who experience persistent symptoms despite conventional treatments.
- Celiac Disease Therapeutics
- Symptom Management Strategies
- Treatment-Resistant Cases
Hepatobiliary Medicine
In the field of liver diseases, the investigator studies treatments for primary biliary cholangitis. Their research involves investigating combination therapies including obeticholic acid and other compounds to improve patient outcomes.
- Liver Disease Management
- Biliary Disorders
- Combination Treatment Approaches
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.